nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—Triamcinolone—psoriatic arthritis	0.258	0.424	CbGbCtD
Aminosalicylic Acid—PTGS2—Betamethasone—psoriatic arthritis	0.222	0.364	CbGbCtD
Aminosalicylic Acid—PTGS2—Dexamethasone—psoriatic arthritis	0.129	0.212	CbGbCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.0162	0.0934	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.0138	0.0794	CbGpPWpGaD
Aminosalicylic Acid—Malabsorption—Methotrexate—psoriatic arthritis	0.0087	0.0422	CcSEcCtD
Aminosalicylic Acid—CHUK—NOD pathway—MEFV—psoriatic arthritis	0.00698	0.0401	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.00646	0.0372	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.00601	0.0346	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—psoriatic arthritis	0.00595	0.0342	CbGpPWpGaD
Aminosalicylic Acid—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.00502	0.0243	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.00473	0.023	CcSEcCtD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.00417	0.024	CbGpPWpGaD
Aminosalicylic Acid—Taste metallic—Methotrexate—psoriatic arthritis	0.00397	0.0193	CcSEcCtD
Aminosalicylic Acid—CHUK—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—psoriatic arthritis	0.00378	0.0217	CbGpPWpGaD
Aminosalicylic Acid—Weight decreased—Auranofin—psoriatic arthritis	0.0037	0.018	CcSEcCtD
Aminosalicylic Acid—Lymphoma—Methotrexate—psoriatic arthritis	0.00361	0.0175	CcSEcCtD
Aminosalicylic Acid—CHUK—Apoptosis—LTA—psoriatic arthritis	0.00359	0.0207	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.00358	0.0173	CcSEcCtD
Aminosalicylic Acid—Jaundice—Auranofin—psoriatic arthritis	0.00356	0.0173	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Auranofin—psoriatic arthritis	0.0034	0.0165	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Prednisolone—psoriatic arthritis	0.00338	0.0164	CcSEcCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—NOS2—psoriatic arthritis	0.00337	0.0194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNFRSF1B—psoriatic arthritis	0.00334	0.0192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD1/2 Signaling Pathway—NOD2—psoriatic arthritis	0.00328	0.0189	CbGpPWpGaD
Aminosalicylic Acid—Peptic ulcer—Prednisolone—psoriatic arthritis	0.00311	0.0151	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Triamcinolone—psoriatic arthritis	0.00311	0.0151	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Methylprednisolone—psoriatic arthritis	0.0031	0.015	CcSEcCtD
Aminosalicylic Acid—CHUK—IL-1 signaling pathway—REL—psoriatic arthritis	0.00307	0.0176	CbGpPWpGaD
Aminosalicylic Acid—Pericarditis—Methotrexate—psoriatic arthritis	0.00292	0.0142	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Triamcinolone—psoriatic arthritis	0.00286	0.0139	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.00286	0.0164	CbGpPWpGaD
Aminosalicylic Acid—Peptic ulcer—Methylprednisolone—psoriatic arthritis	0.00285	0.0138	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Betamethasone—psoriatic arthritis	0.00282	0.0137	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Dexamethasone—psoriatic arthritis	0.00282	0.0137	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Prednisolone—psoriatic arthritis	0.00281	0.0136	CcSEcCtD
Aminosalicylic Acid—Flatulence—Auranofin—psoriatic arthritis	0.00281	0.0136	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Auranofin—psoriatic arthritis	0.00279	0.0135	CcSEcCtD
Aminosalicylic Acid—CHUK—Activation of NF-kappaB in B cells—REL—psoriatic arthritis	0.00268	0.0154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-1 signaling—NOD2—psoriatic arthritis	0.00268	0.0154	CbGpPWpGaD
Aminosalicylic Acid—Anaemia—Auranofin—psoriatic arthritis	0.00264	0.0128	CcSEcCtD
Aminosalicylic Acid—CHUK—NOD pathway—NOD2—psoriatic arthritis	0.00263	0.0151	CbGpPWpGaD
Aminosalicylic Acid—Peptic ulcer—Dexamethasone—psoriatic arthritis	0.0026	0.0126	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Betamethasone—psoriatic arthritis	0.0026	0.0126	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Triamcinolone—psoriatic arthritis	0.00258	0.0125	CcSEcCtD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.00258	0.0148	CbGpPWpGaD
Aminosalicylic Acid—Leukopenia—Auranofin—psoriatic arthritis	0.00255	0.0124	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Prednisone—psoriatic arthritis	0.00246	0.0119	CcSEcCtD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—REL—psoriatic arthritis	0.00239	0.0138	CbGpPWpGaD
Aminosalicylic Acid—Hypothyroidism—Prednisone—psoriatic arthritis	0.00235	0.0114	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—CRP—psoriatic arthritis	0.00233	0.0134	CbGpPWpGaD
Aminosalicylic Acid—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00228	0.0111	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Prednisone—psoriatic arthritis	0.00226	0.011	CcSEcCtD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—psoriatic arthritis	0.00224	0.0129	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Auranofin—psoriatic arthritis	0.00222	0.0108	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisolone—psoriatic arthritis	0.00213	0.0103	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—REL—psoriatic arthritis	0.00207	0.0119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNFRSF1B—psoriatic arthritis	0.00206	0.0119	CbGpPWpGaD
Aminosalicylic Acid—Eruption—Methotrexate—psoriatic arthritis	0.00205	0.00996	CcSEcCtD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.00205	0.0118	CbGpPWpGaD
Aminosalicylic Acid—Dermatitis atopic—Prednisone—psoriatic arthritis	0.00204	0.0099	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.00203	0.0117	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Auranofin—psoriatic arthritis	0.00202	0.00981	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Methotrexate—psoriatic arthritis	0.00197	0.00954	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Triamcinolone—psoriatic arthritis	0.00196	0.0095	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Methylprednisolone—psoriatic arthritis	0.00196	0.00948	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—REL—psoriatic arthritis	0.00195	0.0112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.00192	0.011	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.0019	0.00923	CcSEcCtD
Aminosalicylic Acid—Urticaria—Auranofin—psoriatic arthritis	0.00185	0.00897	CcSEcCtD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.00185	0.0106	CbGpPWpGaD
Aminosalicylic Acid—Abdominal pain—Auranofin—psoriatic arthritis	0.00184	0.00892	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.00182	0.159	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.00179	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.00179	0.156	CbGdCrCtD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—HLA-DRB1—psoriatic arthritis	0.00179	0.0103	CbGpPWpGaD
Aminosalicylic Acid—Vasculitis—Betamethasone—psoriatic arthritis	0.00178	0.00862	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Dexamethasone—psoriatic arthritis	0.00178	0.00862	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.00175	0.153	CbGdCrCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.00174	0.01	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL17A—psoriatic arthritis	0.00174	0.01	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—TNF—psoriatic arthritis	0.00167	0.00962	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.00162	0.00932	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Auranofin—psoriatic arthritis	0.00159	0.00772	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Triamcinolone—psoriatic arthritis	0.00155	0.00753	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisone—psoriatic arthritis	0.00155	0.00751	CcSEcCtD
Aminosalicylic Acid—Vomiting—Auranofin—psoriatic arthritis	0.00148	0.00718	CcSEcCtD
Aminosalicylic Acid—Rash—Auranofin—psoriatic arthritis	0.00147	0.00712	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Auranofin—psoriatic arthritis	0.00147	0.00711	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.00147	0.00843	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.00146	0.00842	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.00145	0.00835	CbGpPWpGaD
Aminosalicylic Acid—Purpura—Triamcinolone—psoriatic arthritis	0.00144	0.00699	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.00143	0.0082	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Auranofin—psoriatic arthritis	0.00138	0.0067	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.00138	0.00791	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.00135	0.00778	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.00134	0.00772	CbGpPWpGaD
Aminosalicylic Acid—CHUK—EBV LMP1 signaling—TNF—psoriatic arthritis	0.00134	0.00772	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling—HLA-DRB1—psoriatic arthritis	0.00134	0.00768	CbGpPWpGaD
Aminosalicylic Acid—Abdominal distension—Prednisolone—psoriatic arthritis	0.00131	0.00637	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—NOD2—psoriatic arthritis	0.0013	0.00746	CbGpPWpGaD
Aminosalicylic Acid—Vasculitis—Methotrexate—psoriatic arthritis	0.00129	0.00628	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—TNF—psoriatic arthritis	0.00129	0.00744	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.00126	0.00726	CbGpPWpGaD
Aminosalicylic Acid—Vascular purpura—Prednisone—psoriatic arthritis	0.00123	0.00595	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.00122	0.00702	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—NOD2—psoriatic arthritis	0.00121	0.00696	CbGpPWpGaD
Aminosalicylic Acid—Abdominal distension—Triamcinolone—psoriatic arthritis	0.00121	0.00586	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00121	0.00585	CcSEcCtD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.00117	0.00671	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.00117	0.00671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.00116	0.00669	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.00115	0.00661	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriatic arthritis	0.00114	0.00658	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.00114	0.00658	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00114	0.00553	CcSEcCtD
Aminosalicylic Acid—Purpura—Prednisone—psoriatic arthritis	0.00114	0.00552	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Activation—REL—psoriatic arthritis	0.00111	0.00641	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HLA-C—psoriatic arthritis	0.00111	0.00637	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.0011	0.00631	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.0011	0.00532	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.0011	0.0957	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.00108	0.0942	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.00108	0.0942	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00105	0.0921	CbGdCrCtD
Aminosalicylic Acid—MPO—Folate Metabolism—TNF—psoriatic arthritis	0.00105	0.00605	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00105	0.00509	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00105	0.00508	CcSEcCtD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—psoriatic arthritis	0.00101	0.00578	CbGpPWpGaD
Aminosalicylic Acid—Weight decreased—Dexamethasone—psoriatic arthritis	0.000985	0.00478	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Betamethasone—psoriatic arthritis	0.000985	0.00478	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000978	0.00562	CbGpPWpGaD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000972	0.00471	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisone—psoriatic arthritis	0.000954	0.00463	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000951	0.00462	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000951	0.00462	CcSEcCtD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.000926	0.00533	CbGpPWpGaD
Aminosalicylic Acid—Weight decreased—Prednisone—psoriatic arthritis	0.000858	0.00416	CcSEcCtD
Aminosalicylic Acid—CHUK—Innate Immune System—MEFV—psoriatic arthritis	0.000841	0.00484	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000836	0.00481	CbGpPWpGaD
Aminosalicylic Acid—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000834	0.00405	CcSEcCtD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000829	0.00477	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000829	0.00402	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000819	0.00397	CcSEcCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000789	0.00454	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNF—psoriatic arthritis	0.000771	0.00443	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.000768	0.00442	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000756	0.00435	CbGpPWpGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000705	0.00342	CcSEcCtD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000668	0.00384	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000668	0.00324	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000661	0.00321	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—psoriatic arthritis	0.000661	0.0032	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000659	0.0032	CcSEcCtD
Aminosalicylic Acid—CHUK—DAP12 interactions—HLA-B—psoriatic arthritis	0.000655	0.00377	CbGpPWpGaD
Aminosalicylic Acid—Hepatitis—Methotrexate—psoriatic arthritis	0.000634	0.00308	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000626	0.00304	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—psoriatic arthritis	0.000622	0.00302	CcSEcCtD
Aminosalicylic Acid—Anaemia—Prednisone—psoriatic arthritis	0.000611	0.00296	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000607	0.00295	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000607	0.00295	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000606	0.00294	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000606	0.00294	CcSEcCtD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.0006	0.00345	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Dexamethasone—psoriatic arthritis	0.00059	0.00286	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betamethasone—psoriatic arthritis	0.00059	0.00286	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—psoriatic arthritis	0.000589	0.00286	CcSEcCtD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000565	0.00325	CbGpPWpGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000559	0.00271	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000557	0.0027	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—psoriatic arthritis	0.000552	0.00268	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000547	0.00265	CcSEcCtD
Aminosalicylic Acid—Urticaria—Triamcinolone—psoriatic arthritis	0.000542	0.00263	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methylprednisolone—psoriatic arthritis	0.000541	0.00262	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—psoriatic arthritis	0.000541	0.00262	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000539	0.00262	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000538	0.00261	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000538	0.00261	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Betamethasone—psoriatic arthritis	0.000538	0.00261	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000534	0.00259	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000534	0.00259	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—psoriatic arthritis	0.000529	0.00256	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—psoriatic arthritis	0.000524	0.00254	CcSEcCtD
Aminosalicylic Acid—Anorexia—Prednisone—psoriatic arthritis	0.000514	0.00249	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—psoriatic arthritis	0.00051	0.00248	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000506	0.00246	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000506	0.00246	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000503	0.00244	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000502	0.00243	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—psoriatic arthritis	0.000494	0.0024	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betamethasone—psoriatic arthritis	0.000492	0.00239	CcSEcCtD
Aminosalicylic Acid—Urticaria—Dexamethasone—psoriatic arthritis	0.000492	0.00239	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisolone—psoriatic arthritis	0.000491	0.00238	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—MEFV—psoriatic arthritis	0.00049	0.00282	CbGpPWpGaD
Aminosalicylic Acid—Abdominal pain—Betamethasone—psoriatic arthritis	0.000489	0.00237	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000489	0.00237	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betamethasone—psoriatic arthritis	0.000489	0.00237	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000489	0.00237	CcSEcCtD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—psoriatic arthritis	0.000476	0.00274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000476	0.00274	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Prednisone—psoriatic arthritis	0.000469	0.00227	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—psoriatic arthritis	0.000468	0.00227	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—psoriatic arthritis	0.000467	0.00227	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000467	0.00226	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000466	0.00226	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisolone—psoriatic arthritis	0.000465	0.00225	CcSEcCtD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000457	0.00263	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000454	0.00261	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Triamcinolone—psoriatic arthritis	0.000451	0.00219	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methylprednisolone—psoriatic arthritis	0.00045	0.00218	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—REL—psoriatic arthritis	0.000449	0.00258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000443	0.00255	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000442	0.00214	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000441	0.00214	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000441	0.00214	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—psoriatic arthritis	0.000441	0.00214	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—psoriatic arthritis	0.000438	0.00212	CcSEcCtD
Aminosalicylic Acid—Vomiting—Triamcinolone—psoriatic arthritis	0.000434	0.0021	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methylprednisolone—psoriatic arthritis	0.000433	0.0021	CcSEcCtD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—NOS2—psoriatic arthritis	0.000433	0.00249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-C—psoriatic arthritis	0.000431	0.00248	CbGpPWpGaD
Aminosalicylic Acid—Rash—Triamcinolone—psoriatic arthritis	0.00043	0.00209	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Triamcinolone—psoriatic arthritis	0.00043	0.00208	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—psoriatic arthritis	0.000429	0.00208	CcSEcCtD
Aminosalicylic Acid—Rash—Methylprednisolone—psoriatic arthritis	0.000429	0.00208	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000429	0.00208	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisone—psoriatic arthritis	0.000428	0.00208	CcSEcCtD
Aminosalicylic Acid—Headache—Triamcinolone—psoriatic arthritis	0.000427	0.00207	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	0.000427	0.00246	CbGpPWpGaD
Aminosalicylic Acid—Headache—Methylprednisolone—psoriatic arthritis	0.000426	0.00207	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—psoriatic arthritis	0.000426	0.00207	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—psoriatic arthritis	0.000426	0.00207	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Betamethasone—psoriatic arthritis	0.000424	0.00205	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000424	0.00205	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000414	0.00238	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Dexamethasone—psoriatic arthritis	0.000409	0.00199	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betamethasone—psoriatic arthritis	0.000409	0.00199	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000408	0.00234	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Triamcinolone—psoriatic arthritis	0.000405	0.00197	CcSEcCtD
Aminosalicylic Acid—Nausea—Methylprednisolone—psoriatic arthritis	0.000404	0.00196	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisone—psoriatic arthritis	0.000397	0.00193	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betamethasone—psoriatic arthritis	0.000394	0.00191	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dexamethasone—psoriatic arthritis	0.000394	0.00191	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—psoriatic arthritis	0.000392	0.0019	CcSEcCtD
Aminosalicylic Acid—Rash—Betamethasone—psoriatic arthritis	0.00039	0.00189	CcSEcCtD
Aminosalicylic Acid—Rash—Dexamethasone—psoriatic arthritis	0.00039	0.00189	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dexamethasone—psoriatic arthritis	0.00039	0.00189	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betamethasone—psoriatic arthritis	0.00039	0.00189	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000389	0.00189	CcSEcCtD
Aminosalicylic Acid—Headache—Betamethasone—psoriatic arthritis	0.000388	0.00188	CcSEcCtD
Aminosalicylic Acid—Headache—Dexamethasone—psoriatic arthritis	0.000388	0.00188	CcSEcCtD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.000384	0.00221	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Prednisone—psoriatic arthritis	0.000369	0.00179	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000368	0.00179	CcSEcCtD
Aminosalicylic Acid—Nausea—Dexamethasone—psoriatic arthritis	0.000368	0.00178	CcSEcCtD
Aminosalicylic Acid—Nausea—Betamethasone—psoriatic arthritis	0.000368	0.00178	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—psoriatic arthritis	0.000358	0.00174	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisone—psoriatic arthritis	0.000357	0.00173	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—psoriatic arthritis	0.000356	0.00173	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—psoriatic arthritis	0.000356	0.00173	CcSEcCtD
Aminosalicylic Acid—Vomiting—Prednisone—psoriatic arthritis	0.000343	0.00166	CcSEcCtD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000342	0.00197	CbGpPWpGaD
Aminosalicylic Acid—Rash—Prednisone—psoriatic arthritis	0.00034	0.00165	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—psoriatic arthritis	0.00034	0.00165	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisone—psoriatic arthritis	0.000338	0.00164	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000332	0.00161	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisone—psoriatic arthritis	0.00032	0.00155	CcSEcCtD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	0.000318	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NOD2—psoriatic arthritis	0.000317	0.00182	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Methotrexate—psoriatic arthritis	0.000308	0.0015	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—psoriatic arthritis	0.000298	0.00145	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—psoriatic arthritis	0.000286	0.00139	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—psoriatic arthritis	0.000284	0.00138	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—psoriatic arthritis	0.000284	0.00138	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—psoriatic arthritis	0.000282	0.00137	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—REL—psoriatic arthritis	0.000273	0.00157	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000272	0.00156	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Methotrexate—psoriatic arthritis	0.000268	0.0013	CcSEcCtD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-B—psoriatic arthritis	0.000255	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-C—psoriatic arthritis	0.000251	0.00144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	0.000247	0.00142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000245	0.00141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CRP—psoriatic arthritis	0.000225	0.00129	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—psoriatic arthritis	0.000215	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	0.000207	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NOD2—psoriatic arthritis	0.000184	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-B—psoriatic arthritis	0.000148	0.000853	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	0.000146	0.000841	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—psoriatic arthritis	0.000131	0.000754	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—psoriatic arthritis	0.000126	0.000722	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—psoriatic arthritis	0.00011	0.000635	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—psoriatic arthritis	6.54e-05	0.000376	CbGpPWpGaD
